Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award: Doctoral Foreign Study Award (DFSA)

Direct Payment

$120,000.00

Investigating Neurodegeneration Through the Eye Using Multimodal Retinal Imaging

EF 2024-25

Résumé
Neurodegenerative diseases are a significant global health issue, affecting millions by progressively damaging the nervous system. Whilst there are currently no cures for these conditions, identifying reliable biomarkers for early detection and disease progression is crucial. The retina-the light-sensitive part at the back of the eye-shares structural and functional similarities with the brain, making it a promising area for studying neurodegenerative diseases. We built an innovative project using different types of non-invasive retinal imaging methods to better understand ongoing neurodegenerative processes in individuals with Multiple Sclerosis (MS), Motor Neuron Disease (MND), and Parkinson's Disease (PD). Our project is divided into two phases: Phase One: We will analyse data from a previous study, the FutureMS cohort, which included over 400 individuals in Scotland with relapsing-remitting MS. Participants in this study were followed for three years to track neuroinflammatory and neurodegenerative changes. We will focus on a subset of participants with retinal imaging data, examining retinal changes over time and their association with clinical outcomes and brain imaging results. Phase Two: We will recruit individuals with MND and PD through NeuroCARE, a registry in Scotland that supports clinical care, research, and audits for people with neurological disorders. Using similar retinal imaging methods as in Phase One, we will scan the retinas of these participants to compare retinal changes across MS, MND, and PD, aiming to identify any disease-specific patterns. Our research aims to uncover novel retinal features that could aid in the early detection and monitoring of neurodegenerative diseases, ultimately contributing to the development of personalised therapeutic interventions.
Programme
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
516859
Name
Ozzoude Miracle E
Country
United Kingdom
Orgtype
Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating Neurodegeneration Through the Eye Using Multimodal Retinal Imaging
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Award: Doctoral Foreign Study Award (DFSA)
Keyworddelim
Motor Neuron Disease/ Amyotrophic Lateral Sclerosis; Multiple Sclerosis; Neurodegenerative Disease; Neuroinflammatory Disease; Oct-Angiography (Oct-A); Ophthalmology; Optical Coherence Tomography (Oct); Parkinson'S Disease; Retinal Imaging; Vision Science
Abstract
Neurodegenerative diseases are a significant global health issue, affecting millions by progressively damaging the nervous system. Whilst there are currently no cures for these conditions, identifying reliable biomarkers for early detection and disease progression is crucial. The retina-the light-sensitive part at the back of the eye-shares structural and functional similarities with the brain, making it a promising area for studying neurodegenerative diseases. We built an innovative project using different types of non-invasive retinal imaging methods to better understand ongoing neurodegenerative processes in individuals with Multiple Sclerosis (MS), Motor Neuron Disease (MND), and Parkinson's Disease (PD). Our project is divided into two phases: Phase One: We will analyse data from a previous study, the FutureMS cohort, which included over 400 individuals in Scotland with relapsing-remitting MS. Participants in this study were followed for three years to track neuroinflammatory and neurodegenerative changes. We will focus on a subset of participants with retinal imaging data, examining retinal changes over time and their association with clinical outcomes and brain imaging results. Phase Two: We will recruit individuals with MND and PD through NeuroCARE, a registry in Scotland that supports clinical care, research, and audits for people with neurological disorders. Using similar retinal imaging methods as in Phase One, we will scan the retinas of these participants to compare retinal changes across MS, MND, and PD, aiming to identify any disease-specific patterns. Our research aims to uncover novel retinal features that could aid in the early detection and monitoring of neurodegenerative diseases, ultimately contributing to the development of personalised therapeutic interventions.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ozzoude, Miracle E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~